---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-24-198362"
form_type: "8-K"
ticker: "FNCHQ"
cik: "0001733257"
company_name: "Finch Therapeutics Group, Inc."
filed_at: "2024-08-12T23:59:59+00:00"
generated_at: "2026-05-31T10:05:08.262693+00:00"
event_type: "litigation"
sentiment: "positive"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Jury awards Finch $25M upfront plus royalties in patent infringement verdict against Ferring

## Summary
- Jury found Ferring willfully infringed on Finch/UMN patents for microbiome therapy Rebyota.
- Damages include $25.0M upfront payment and $0.815M in running royalties through trial date.
- Two claims (one from '309, one from '080 patents) were found invalid; remaining claims valid.
- Finch expects Ferring to file post-trial motions and appeal the judgment.
- Trial began Aug 5, 2024; verdict rendered Aug 9, 2024 in U.S. District Court for Delaware.

## SEC filing metadata
- accession: 0001193125-24-198362
- form_type: 8-K
- ticker: FNCHQ
- cik: 0001733257
- company_name: Finch Therapeutics Group, Inc.
- filed_at: 2024-08-12T23:59:59+00:00
- event_type: litigation
- sentiment: positive
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1733257/000119312524198362/0001193125-24-198362-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1733257/000119312524198362/d801504d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-24-198362
- JSON: https://secwatch.observer/filing/0001193125-24-198362.json
- Plain text: https://secwatch.observer/filing/0001193125-24-198362.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.